which should mean that if leronlimab has similar e
Post# of 148268
(Total Views: 855)
Posted On: 06/12/2024 1:25:38 PM
Quote:
which should mean that if leronlimab has similar efficacy and far less - all the way to zero - side effects, it HAS to be approved?
Similar efficacy is to low of a bar for leronlimab. We know what lesser drugs for CCR5 blockade have shown in Alzheimer's. We know a lot of what CCR5 blockade does overall. There is no way that leronlimab doesn't far surpass any approved drug out there.
(20)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼